GlassScriptPhysician profile
Temple W Simpson
NPI 1285822148
$13,233.77
in general payments reported to CMS, 2019-2025
54 companies · $2,762 in 2025
The $2,762 reported for 2025 was more than what 95% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,134 · 2022: $2,364 · 2023: $2,583 · 2024: $2,390 · 2025: $2,762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,653 · Gift: $59.40 · Education: $22.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,653.15 |
| Gift | $59.40 |
| Education | $22.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,504.05 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,370.69 | 2021-2025 | Mounjaro, Jardiance, Trulicity |
| Abbott Laboratories | $954.64 | 2021-2025 | Freestyle Libre, Freestyle Libre 3 |
| Medtronic, INC. | $775.77 | 2022-2025 | Minimed 780g, Intellis Adaptivestim |
| Abbvie INC. | $740.77 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $721.74 | 2021-2025 | |
| Xeris Pharmaceuticals, INC. | $669.09 | 2021-2025 | Recorlev, Gvoke Hypopen |
| Insulet Corporation | $632.40 | 2021-2025 | Omnipod |
| Bayer Healthcare Pharmaceuticals INC. | $613.07 | 2021-2025 | |
| Corcept Therapeutics | $469.77 | 2021-2025 | Korlym |
| Mannkind Corporation | $400.14 | 2021-2023 | Afrezza |
| Amgen INC. | $391.03 | 2021-2025 | Tepezza, Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $380.14 | 2021-2025 | Jardiance, Synjardy, Tradjenta |
| Ibsa Pharma INC. | $314.16 | 2021-2025 | Tirosint, Licart, Flector |
| Horizon Therapeutics Plc | $256.83 | 2021-2023 | Tepezza |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascendis Pharma Endocrinology INC | $225.06 | 2023-2025 | Yorvipath |
| Novartis Pharmaceuticals Corporation | $213.98 | 2022-2025 | |
| Cequr Corporation | $213.42 | 2022-2025 | Cequr Simplicity |
| Astrazeneca Pharmaceuticals LP | $207.09 | 2021-2022 | |
| Antares Pharma, INC. | $178.45 | 2022-2024 | Xyosted, Tlando, Nocdurna |
| Zealand Pharma US, INC. | $144.71 | 2021-2022 | |
| Madrigal Pharmaceuticals | $135.99 | 2025 | Rezdiffra |
| Ascensia Diabetes Care US INC. | $122.33 | 2023-2025 | |
| Recordati_rare_diseases_inc. | $120.74 | 2024-2025 | Isturisa, Signifor Lar |
| Tolmar, INC. | $119.39 | 2023-2025 | Jatenzo |
| Amneal Pharmaceuticals LLC | $118.01 | 2022-2025 | Unithroid |
| Radius Health, INC. | $116.04 | 2021-2025 | Tymlos |
| Beta Bionics, INC. | $111.42 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Ultragenyx Pharmaceutical INC. | $110.55 | 2021-2022 | |
| Averitas Pharma INC. | $107.85 | 2024-2025 | Qutenza |
| Dexcom, INC. | $82.97 | 2021-2024 | Dexcom G6 Transmitter |
| Nevro Corp. | $64.01 | 2023-2024 | Senza |
| Alexion Pharmaceuticals, INC. | $63.05 | 2021-2024 | Strensiq |
| Merck Sharp & Dohme LLC | $62.88 | 2021 | |
| Endo Pharmaceuticals INC. | $52.00 | 2021 | |
| Tandem Diabetes Care, INC. | $47.73 | 2021 | |
| Becton, Dickinson and Company | $45.62 | 2021 | |
| Shield Therapeutics INC | $37.53 | 2023-2024 | Accrufer |
| Astellas Pharma US INC | $36.29 | 2024-2025 | Veozah |
| Kyowa Kirin, INC. | $28.90 | 2024 | Crysvita |
| Neurocrine Biosciences, INC. | $28.44 | 2025 | |
| Intuity Medical INC | $26.04 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Sequel Med Tech, LLC | $23.29 | 2025 | Twiist |
| Opko Pharmaceuticals, LLC | $22.80 | 2024 | Rayaldee |
| Lifescan, INC. | $20.86 | 2021 | |
| Scynexis, INC. | $20.76 | 2022 | |
| Arkray USA, INC. | $20.43 | 2023 | |
| Halozyme INC | $19.81 | 2023 | |
| Renalytix Ai, INC. | $18.98 | 2022 | |
| Acerus Pharmaceuticals Corporation | $18.24 | 2022 | |
| Almatica Pharma LLC | $14.67 | 2025 | Loreev Xr |
| Alnylam Pharmaceuticals INC. | $13.73 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.87 | 2021 | |
| Currax Pharmaceuticals LLC | $12.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Temple Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.